Rheolytic thrombectomy in patients with ST-elevation myocardial infarction and large thrombus burden: the Thoraxcenter experience

Loading...
Thumbnail Image

Date

Authors

Sianos, G.
Papafaklis, M. I.
Vaina, S.
Daemen, J.
van Mieghem, C. A.
Van Domburg, R. T.
Michalis, L. K.
de Jaegere, P.
Serruys, P. W.

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Type of the conference item

Journal type

peer-reviewed

Educational material type

Conference Name

Journal name

J Invasive Cardiol

Book name

Book series

Book edition

Alternative title / Subtitle

Description

OBJECTIVES: To determine the impact of Rheolytic thrombectomy (RT) on the clinical and angiographic outcome of patients with ST-elevation myocardial infarction (STEMI) and large thrombus burden (LTB). METHODS: Two hundred sixty-six consecutive patients who presented from April 2002 until December 2004 with STEMI and LTB were retrospectively analyzed. LTB was defined as definite presence of thrombus with the greatest dimension greater > or = 2 vessel diameters by visual assessment. RT, as well as the interventional procedure and the peri-procedural pharmacological therapy, was at the discretion of the operator. All patients were followed for major adverse cardiac events (MACE) defined as death, non-fatal myocardial infarction (MI) and infarct-related artery revascularization. Pre- and post-procedural thrombolysis in myocardial infarction (TIMI) flow and thrombus burden as well as myocardial blush, distal embolization and no reflow were also determined. RESULTS: Complete follow-up was available in all patients; mean duration was 17 +/- 8.7 months. RT was used in 75 patients (28.2%). Stents were implanted in 251 (94.4%) patients; drug-eluting stents in 210 (84.6%) patients (15.5% sirolimus-eluting stents and 69.1% paclitaxel-eluting stents). The 2-year cumulative survival and MACE-free survival were higher in the RT compared to the non-RT group (92% vs. 82.7%, p = 0.051 and 87.7% vs. 69.9%, p = 0.004, respectively). Post-procedure indices (TIMI 3 flow, absence of thrombus and myocardial blush grade 3) of angiographic outcome were significantly better in the RT group. RT was an independent predictor of MACE (HR: 0.45, 95% CI: 0.22-0.93, p = 0.03). CONCLUSIONS: RT significantly improves the clinical and angiographic outcome of patients with STEMI and large thrombus burden.

Description

Keywords

Aged, Coronary Angiography, Coronary Thrombosis/*complications/mortality/physiopathology/*therapy, Drug Delivery Systems, *Electrocardiography, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Infarction/*complications/physiopathology/radiography/therapy, Recurrence, Retrospective Studies, Severity of Illness Index, Stents, Survival Analysis, Thrombectomy/*methods, Treatment Outcome

Subject classification

Citation

Link

http://www.ncbi.nlm.nih.gov/pubmed/16883024

Language

en

Publishing department/division

Advisor name

Examining committee

General Description / Additional Comments

Institution and School/Department of submitter

Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής

Table of contents

Sponsor

Bibliographic citation

Name(s) of contributor(s)

Number of Pages

Course details

Endorsement

Review

Supplemented By

Referenced By